Clinical Trial 40253


Long Beach, CA 90806

Study Summary:

A Phase 2a, Multicenter, Randomized, Double-Blind,
Placebo-Controlled, 3-Arm Study to Assess the Safety, Tolerability,
PK Profile, and Symptom Response of a 7-Day Dosing with
REL-1017 25 mg QD and 50 mg QD as Adjunctive Therapy in the
Treatment of Patients Diagnosed with Major Depressive Disorder

Qualified Participants Must:

• Males and Females between 18 and 65 years of age
• Diagnosed with recurrent MDD

Qualified Participants May Receive:

Compensation for time and travel 

Study is Available At:

CNS Network
2600 Redondo Ave
Long Beach, CA 90806
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.